Benzinga's Top Initiations
March 10, 2014 at 08:41 AM EDT
Analysts at UBS initiated coverage on shares of Concert Pharmaceuticals (NASDAQ: CNCE) with a “buy” rating. The target price for Concert ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.